Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Research output: Contribution to journal › Journal article › Research › peer-review
Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly effective. We aimed to establish whether add-on of simvastatin, a statin with anti-inflammatory properties, improves this efficacy.
| Original language | English |
|---|---|
| Journal | Lancet Neurology |
| Volume | 10 |
| Issue number | 8 |
| Pages (from-to) | 691-701 |
| Number of pages | 11 |
| ISSN | 1474-4422 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 40194325